Raphael Pharmaceutical Inc (RAPH)
1.64
0.00 (0.00%)
USD |
OTCM |
Jun 12, 16:00
Raphael Pharmaceutical Net Income (Quarterly): -0.55M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.55M |
December 31, 2023 | -0.559M |
September 30, 2023 | -1.406M |
June 30, 2023 | -0.417M |
March 31, 2023 | -0.264M |
December 31, 2022 | -1.915M |
September 30, 2022 | -2.255M |
Date | Value |
---|---|
June 30, 2022 | -0.627M |
March 31, 2022 | -0.185M |
December 31, 2021 | -0.566M |
September 30, 2021 | -0.416M |
June 30, 2021 | -0.642M |
March 31, 2021 | -0.255M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-2.255M
Minimum
Sep 2022
-0.185M
Maximum
Mar 2022
-0.7736M
Average
-0.559M
Median
Dec 2023
Net Income (Quarterly) Benchmarks
InspireMD Inc | -7.032M |
Pluri Inc | -5.293M |
BiomX Inc | -17.33M |
Alpha Tau Medical Ltd | -7.981M |
Holdco Nuvo Group DG Ltd | -- |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 0.547M |
EPS Diluted (Quarterly) | -0.03 |
Enterprise Value | 30.32M |
Earnings Yield | -10.98% |